KLOW is a synergistic four-peptide blend combining GHK-Cu, TB-500, BPC-157, and KPV. It has attracted growing interest in research focused on tissue repair, inflammation control, and skin regeneration.
Studies have shown that KLOW leverages complementary mechanisms: BPC-157 promotes angiogenesis and tendon healing, TB-500 facilitates cell migration and extracellular matrix remodeling, KPV exerts potent anti-inflammatory effects via NF-κB inhibition, and GHK-Cu stimulates collagen synthesis and wound healing. Together, they offer a comprehensive approach to tissue regeneration and recovery. This blend may also play a role in gut health support, post-injury recovery, joint health, and management of chronic inflammatory conditions .
Synergistic tissue repair and accelerated wound healing
Inflammation modulation and NF-κB pathway inhibition
Collagen synthesis and skin regeneration
Angiogenesis and extracellular matrix remodeling
Gastrointestinal health and chronic inflammation research